Skip to main content
Top
Published in: Abdominal Radiology 9/2016

01-09-2016 | JSAR

Massive splenic infarction and splenic venous thrombosis observed in a patient with acute splenic syndrome of sickle cell traits on contrast-enhanced thin-slice computed tomography

Authors: Takana Yamakawa Hayashi, Izuru Matsuda, Kazuchika Hagiwara, Tomoko Takayanagi, Akifumi Hagiwara

Published in: Abdominal Radiology | Issue 9/2016

Login to get access

Abstract

We report a case of splenic infarction in a patient with sickle cell traits (SCT), focusing on the computed tomography (CT) findings. The patient was an African-American man in his twenties with no past medical history who experienced sudden left upper quadrant pain while climbing a mountain (over 3000 m above sea level). Dynamic contrast-enhanced CT revealed massive non-segmental splenic infarction accompanied with nodule-like preserved splenic tissue. The region of splenic infarction did not coincide with the arterial vascular territory and differed from the features of infarction caused by large arterial embolism. In addition, thrombotic occlusion of the distal splenic vein was depicted on plain and contrast-enhanced thin-slice CT images. Early-phase contrast-enhanced images also showed inhomogeneous enhancement of the hepatic parenchyma. The patient’s symptoms improved with conservative therapy. A hemoglobin electrophoresis test confirmed the diagnosis of SCT. SCT is usually asymptomatic, but hypoxic environments may induce acute splenic syndrome, which is commonly manifested as splenic infarction. We observed splenic venous thrombosis and inhomogeneous hepatic parenchymal enhancement in addition to a huge splenic infarction in our patient. To the best of our knowledge, this is the first report describing the specific imaging findings, particularly splenic venous thrombosis and inhomogeneous hepatic parenchymal enhancement, of acute splenic syndrome in a patient with previously undiagnosed SCT. These findings demonstrate the pathophysiology of SCT, and may help with the diagnosis of this disease.
Literature
1.
go back to reference Pauling L, Itano HA, Singer SJ, Wells IC (1949) Sickle cell anemia a molecular disease. Science 110:543–548CrossRefPubMed Pauling L, Itano HA, Singer SJ, Wells IC (1949) Sickle cell anemia a molecular disease. Science 110:543–548CrossRefPubMed
2.
go back to reference Bookchin RM, Lew VL (1996) Pathophysiology of sickle cell anemia. Hematol Oncol Clin North Am 10:1241–1253CrossRefPubMed Bookchin RM, Lew VL (1996) Pathophysiology of sickle cell anemia. Hematol Oncol Clin North Am 10:1241–1253CrossRefPubMed
3.
go back to reference Balla SK (1998) Sickle cell disease: clinical management. Baillieres Clin Haematol 11:185–214CrossRef Balla SK (1998) Sickle cell disease: clinical management. Baillieres Clin Haematol 11:185–214CrossRef
4.
go back to reference Ashley-Koch A, Yang Q, Olney RS (2000) Sickle hemoglobin (HbS) allele and sickle cell disease: a HUGE review. Am J Epidemiol 151:839–845CrossRefPubMed Ashley-Koch A, Yang Q, Olney RS (2000) Sickle hemoglobin (HbS) allele and sickle cell disease: a HUGE review. Am J Epidemiol 151:839–845CrossRefPubMed
5.
go back to reference Diggs LW, Ahmann CF, Bibb J (1933) The incidence and significance of sickle cell trait. Ann Intern Med 7:769–778CrossRef Diggs LW, Ahmann CF, Bibb J (1933) The incidence and significance of sickle cell trait. Ann Intern Med 7:769–778CrossRef
6.
go back to reference Sears DA (1978) The morbidity of sickle cell trait: a review of the literature. Am J Med 64:1021–1036CrossRefPubMed Sears DA (1978) The morbidity of sickle cell trait: a review of the literature. Am J Med 64:1021–1036CrossRefPubMed
7.
go back to reference Scordino D, Kirsch T (2013) Splenic infarction at high altitude secondary to sickle cell trait. Am J Emerg Med 31(446):e1–e3PubMed Scordino D, Kirsch T (2013) Splenic infarction at high altitude secondary to sickle cell trait. Am J Emerg Med 31(446):e1–e3PubMed
8.
go back to reference Murano T, Fox AD, Anjaria D (2013) Acute splenic syndrome in an African-American male with sickle cell trait on a commercial airplane flight. J Emerg Med 45:e161–e165CrossRefPubMed Murano T, Fox AD, Anjaria D (2013) Acute splenic syndrome in an African-American male with sickle cell trait on a commercial airplane flight. J Emerg Med 45:e161–e165CrossRefPubMed
9.
go back to reference Stock AE (1956) Splenic infarction associated with high altitude flying and sickle cell trait. Ann Intern Med 44:554–556CrossRefPubMed Stock AE (1956) Splenic infarction associated with high altitude flying and sickle cell trait. Ann Intern Med 44:554–556CrossRefPubMed
10.
go back to reference Funakoshi H, Takada T, Miyahara M, et al. (2010) Sickle cell trait as a cause of splenic infarction while climbing Mt. Fuji. Intern Med 49:1827–1829CrossRefPubMed Funakoshi H, Takada T, Miyahara M, et al. (2010) Sickle cell trait as a cause of splenic infarction while climbing Mt. Fuji. Intern Med 49:1827–1829CrossRefPubMed
11.
go back to reference Norii T, Freeman TH, Alseidi A, Butler WP, Gelford BL (2011) Pressurized flight immediately after splenic infarction in two patients with the sickle cell trait. Aviat Space Environ Med 82:58–60CrossRefPubMed Norii T, Freeman TH, Alseidi A, Butler WP, Gelford BL (2011) Pressurized flight immediately after splenic infarction in two patients with the sickle cell trait. Aviat Space Environ Med 82:58–60CrossRefPubMed
12.
go back to reference Morishima A, Schofer JM, Pelletier P, McKee JM (2008) Images in emergency medicine: splenic infarction due to sickle cell trait after climbing Mt. Fuji. West J Emerg Med 9:179PubMedPubMedCentral Morishima A, Schofer JM, Pelletier P, McKee JM (2008) Images in emergency medicine: splenic infarction due to sickle cell trait after climbing Mt. Fuji. West J Emerg Med 9:179PubMedPubMedCentral
13.
go back to reference Abeysekera WY, de Silva WD, Pinnaduwa SS, Banagala AS (2012) Acute massive splenic infarction with splenic vein thrombosis following altitude exposure of a Sri Lankan male with undetected sickle cell trait. High Alt Med Biol 13:288–290CrossRefPubMed Abeysekera WY, de Silva WD, Pinnaduwa SS, Banagala AS (2012) Acute massive splenic infarction with splenic vein thrombosis following altitude exposure of a Sri Lankan male with undetected sickle cell trait. High Alt Med Biol 13:288–290CrossRefPubMed
14.
go back to reference López de Guimaraes D, Menacho López J, Villanueva Palacios J, Mosquera Vásquez V (2009) [Splenic infarction at high altitude, Huaraz-Peru (3,100 masl).] Rev Gastroenterol Peru 29:179–84 [In Spanish] López de Guimaraes D, Menacho López J, Villanueva Palacios J, Mosquera Vásquez V (2009) [Splenic infarction at high altitude, Huaraz-Peru (3,100 masl).] Rev Gastroenterol Peru 29:179–84 [In Spanish]
15.
go back to reference Martin JA, Hamilton BE, Sutton PD, et al. (2010) Births: final data for 2007. Natl Vital Stat Rep 58:1–77PubMed Martin JA, Hamilton BE, Sutton PD, et al. (2010) Births: final data for 2007. Natl Vital Stat Rep 58:1–77PubMed
Metadata
Title
Massive splenic infarction and splenic venous thrombosis observed in a patient with acute splenic syndrome of sickle cell traits on contrast-enhanced thin-slice computed tomography
Authors
Takana Yamakawa Hayashi
Izuru Matsuda
Kazuchika Hagiwara
Tomoko Takayanagi
Akifumi Hagiwara
Publication date
01-09-2016
Publisher
Springer US
Published in
Abdominal Radiology / Issue 9/2016
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-016-0786-8

Other articles of this Issue 9/2016

Abdominal Radiology 9/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.